Lv32
215 积分 2020-11-07 加入
Epidemiology of liver diseases: global disease burden and forecasted research trends
8天前
已完结
Global burden of metabolic diseases, 1990–2021
8天前
已完结
Current status and future trends of the global burden of MASLD
8天前
已完结
Beyond obesity: lean metabolic dysfunction-associated steatohepatitis from unveiling molecular pathogenesis to therapeutic advancement
12天前
已完结
Special Population: Lean MASH
12天前
已关闭
Special Population: Lean MASH
12天前
已关闭
A Phase 3 Trial of Brepocitinib in Dermatomyositis
19天前
已完结
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial
20天前
已完结
Epidemiology of Sjögren syndrome
21天前
已完结
Update on the pathophysiology and treatment of primary Sjögren syndrome
21天前
已完结
皖公网安备34019202002308
